false
Catalog
Diabetes and Weight Management Part 1
Pharmacological Agents for Diabetes & Obesity Info ...
Pharmacological Agents for Diabetes & Obesity Infographic
Back to course
Pdf Summary
This infographic provides guidelines for the use of pharmacologic agents in the treatment of diabetes and obesity based on recommendations from the American Diabetes Association's Standards of Care in Diabetes 2023. Incretins and weight management are highlighted as key treatments for type 2 diabetes. They have been shown to delay the progression from prediabetes to type 2 diabetes and are highly beneficial in treating type 2 diabetes. Incretins also help improve glycemia and reduce the need for glucose-lowering medications. Additionally, they substantially reduce A1C and fasting glucose levels and have been shown to promote sustained diabetes remission for at least two years. In terms of weight management, there is strong and consistent evidence that obesity management can aid in achieving and maintaining meaningful weight loss and reducing obesity-associated health risks.<br /><br />The infographic also presents treatment options for overweight and obesity in type 2 diabetes based on body mass index (BMI) categories. These options include intensive behavioral counseling, obesity pharmacotherapy, and bariatric surgery. The choice of glucose-lowering medications should take into consideration the patient's weight, and medications that are associated with weight gain should be minimized. Obesity pharmacotherapy can be effective as an adjunct to nutrition, physical activity, and behavioral counseling for selected individuals with type 2 diabetes and a BMI of 27 kg/m2 or higher. However, the potential benefits and risks of pharmacotherapy must be considered. The infographic also provides a list of specific glucose-lowering medications categorized as very high, high, intermediate, or neutral, based on their potential for weight loss. Overall, this infographic serves as a visual guide to the guidelines for the use of pharmacologic agents in the management of diabetes and obesity.
Keywords
pharmacologic agents
diabetes treatment
obesity treatment
American Diabetes Association
Standards of Care in Diabetes 2023
incretins
weight management
type 2 diabetes
glucose-lowering medications
obesity management
American Diabetes Association 2451 Crystal Drive, Suite 900, Arlington, VA 22202
1-800-DIABETES
Follow us on
Copyright All rights reserved.
×
Please select your language
1
English